Roche Aktie
277,60
EUR
+1,10
EUR
+0,40
%
258,50
CHF
+1,50
CHF
+0,58
%
Werbung
Roche Aktie Analyse
29.03.05 | Roche Buy | Sarasin Research | |
24.03.05 | Roche Sector Outperform | Vontobel | |
22.03.05 | Roche Buy | Sarasin Research | |
16.03.05 | Roche Buy | Helvea | |
16.03.05 | Roche In-Line | Goldman Sachs | |
09.03.05 | Roche Buy | Sarasin Research | |
07.03.05 | Roche Neutral | Helvea | |
07.03.05 | Roche Neutral | Helvea | |
Werbung
|
|||
28.02.05 | Roche Buy | Sarasin Research | |
17.02.05 | Roche Hold | Crédit Suisse | |
11.02.05 | Roche Marketperformer | Sparkasse KölnBonn | |
09.02.05 | Roche Buy | Merrill Lynch | |
04.02.05 | Roche Buy | Sarasin Research | |
03.02.05 | Roche Buy | Sarasin Research | |
03.02.05 | Roche Kaufen | LB Baden-Württemberg | |
03.02.05 | Roche In-Line | Goldman Sachs | |
02.02.05 | Roche Buy | Sarasin Research | |
02.02.05 | Roche Halten | Helaba Trust | |
02.02.05 | Roche Buy | Sarasin Research | |
01.02.05 | Roche Halten | Helaba Trust | |
31.01.05 | Roche Buy | Sarasin Research | |
31.01.05 | Roche Neutral | Credit Suisse First Boston | |
21.01.05 | Roche Buy | Sarasin Research | |
18.01.05 | Roche Buy | Merrill Lynch |
Werbung
Werbung